LeMaitre Vascular Research Development Over Time
| LMAT Stock | USD 86.78 0.73 0.83% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out LeMaitre Vascular Performance and LeMaitre Vascular Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will LeMaitre introduce new products? Factors like these will boost the valuation of LeMaitre Vascular. Expected growth trajectory for LeMaitre significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about LeMaitre Vascular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Dividend Share 0.76 | Earnings Share 2.35 | Revenue Per Share | Quarterly Revenue Growth 0.114 |
The market value of LeMaitre Vascular is measured differently than its book value, which is the value of LeMaitre that is recorded on the company's balance sheet. Investors also form their own opinion of LeMaitre Vascular's value that differs from its market value or its book value, called intrinsic value, which is LeMaitre Vascular's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because LeMaitre Vascular's market value can be influenced by many factors that don't directly affect LeMaitre Vascular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that LeMaitre Vascular's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LeMaitre Vascular represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, LeMaitre Vascular's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Research Development Analysis
Compare LeMaitre Vascular and related stocks such as Quidel, Acadia Healthcare, and Haemonetics Research Development Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QDEL | 4.1 M | 26.3 M | 27.7 M | 34.2 M | 37.9 M | 35.5 M | 38.7 M | 33.6 M | 51.6 M | 52.6 M | 84.3 M | 95.7 M | 187.9 M | 246.8 M | 218.7 M | 251.5 M | 264.1 M |
| ACHC | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| HAE | 15.8 M | 36.8 M | 48.6 M | 54.2 M | 54.2 M | 55.9 M | 47.3 M | 39.2 M | 35.7 M | 39.1 M | 40.7 M | 55.2 M | 58.6 M | 63 M | 69.4 M | 79.8 M | 83.8 M |
| ATRC | 2.5 M | 11.9 M | 12.1 M | 13.4 M | 18.6 M | 25.7 M | 35.8 M | 34.1 M | 34.7 M | 41.2 M | 43.1 M | 48.5 M | 57.3 M | 73.9 M | 96.2 M | 110.6 M | 116.1 M |
| INSP | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 6.2 M | 7.4 M | 12.8 M | 26.1 M | 37.4 M | 68.6 M | 116.5 M | 114.1 M | 131.2 M | 137.8 M |
| TWST | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 19.2 M | 20.3 M | 35.7 M | 43 M | 69.1 M | 120.3 M | 106.9 M | 90.9 M | 80.3 M | 92.3 M | 66.4 M |
| NHC | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.09 | 0.05 | 0.15 | 0.03 | 0.08 | 0.08 | 0.092 | 0.0966 |
| PRCT | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 16.3 M | 19 M | 29 M | 48.4 M | 62.3 M | 71.6 M | 75.2 M |
| PAHC | 1.6 M | 7.2 M | 6.6 M | 8.2 M | 9.5 M | 11 M | 9.4 M | 10 M | 12.1 M | 13.7 M | 17.8 M | 20.8 M | 24.4 M | 29.2 M | 23.7 M | 27.3 M | 28.6 M |
LeMaitre Vascular and related stocks such as Quidel, Acadia Healthcare, and Haemonetics Research Development description
My Equities
My Current Equities and Potential Positions
| LeMaitre Vascular | LMAT |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 63 Second Avenue, |
| Exchange | NASDAQ Exchange |
USD 86.78
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.